Stay updated on Nivolumab and Relatlimab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Relatlimab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Relatlimab in Melanoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The revision tag on the page updated from v3.6.4 to v3.6.5. This reflects a new version of the page in the revision history.
    Difference
    0.1%
    Check dated 2026-08-11T08:23:00.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    A new Revision: v3.6.4 tag has been added. The previous Revision: v3.6.3 tag, along with certain related topics text (Melanoma, MedlinePlus Genetics), was removed.
    Difference
    0.2%
    Check dated 2026-07-28T03:26:16.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Metadata and related topics were updated, and the revision tag was changed from v3.6.2 to v3.6.3. These changes adjust navigation and context without altering the study details.
    Difference
    0.2%
    Check dated 2026-07-06T18:21:31.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.6.0 to v3.6.2 to reflect a new build. This update records the updated software version without changing the page’s content or functionality.
    Difference
    0.1%
    Check dated 2026-06-29T14:35:47.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Added related topic tags for Melanoma and MedlinePlus Genetics. These additions connect the study page with broader melanoma-related and genetics resources, providing quick access to contextual materials.
    Difference
    0.2%
    Check dated 2026-06-22T11:22:39.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    The page now indicates that the study is no longer recruiting participants and adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study). The Intervention / Treatment label was updated to Intervention/Treatment and the site revision is updated to v3.6.0 from v3.5.5.
    Difference
    0.4%
    Check dated 2026-06-15T08:31:10.000Z thumbnail image

Stay in the know with updates to Nivolumab and Relatlimab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Relatlimab in Melanoma Clinical Trial page.